Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been ...
The fill-finish market—a traditionally stable one—is increasingly adopting new technologies. Research from our 12th Annual Report and Survey of Biopharmaceutical Manufacturing, and other studies ...
The "Biologics Fill Finish Services Market Industry Trends and Global Forecasts to 2035, by Type of Primary Packaging Container, Type of Biologic Manufactured, Scale of Operation, Therapeutic Area, ...
The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...
SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...
Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial ...
Growth of the biopharmaceutical industry. Rising technological advancements in fill-finish manufacturing processes. Rising adoption of prefilled syringes for parenteral dosage forms. The study ...
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire Integrity Bio, Inc., a privately ...
PCI Pharma, a Philadelphia-based CDMO, will spend $100 million to beef up aseptic liquid fill-finish manufacturing operations at its Bedford, New Hampshire, facility. The project follows PCI’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback